Related Experiment Video
Updated: Jan 22, 2026

Assembly of Nucleosomal Arrays from Recombinant Core Histones and Nucleosome Positioning DNA
Published on: September 10, 2013
Chemical genomics reveals histone deacetylases are required for core regulatory transcription
Berkley E Gryder1, Lei Wu2, Girma M Woldemichael3
1Genetics Branch, NCI, NIH, Bethesda, MD, 20892, USA.
Abstract:
Identity determining transcription factors (TFs), or core regulatory (CR) TFs, are governed by cell-type specific super enhancers (SEs). Drugs to selectively inhibit CR circuitry are of high interest for cancer treatment. In alveolar rhabdomyosarcoma, PAX3-FOXO1 activates SEs to induce the expression of other CR TFs, providing a model system for studying cancer cell addiction to CR transcription. Using chemical genetics, the systematic screening of chemical matter for a biological outcome, here we report on a screen for epigenetic chemical probes able to distinguish between SE-driven transcription and constitutive transcription. We find that chemical probes along the acetylation-axis, and not the methylation-axis, selectively disrupt CR transcription. Additionally, we find that histone deacetylases (HDACs) are essential for CR TF transcription. We further dissect the contribution of HDAC isoforms using selective inhibitors, including the newly developed selective HDAC3 inhibitor LW3. We show HDAC1/2/3 are the co-essential isoforms that when co-inhibited halt CR transcription, making CR TF sites hyper-accessible and disrupting chromatin looping.
Insights
Chemical probes targeting the acetylation axis, not methylation, disrupt cancer cell transcription. Histone deacetylases (HDACs) 1, 2, and 3 are essential for core regulatory transcription, offering new cancer treatment strategies.
Area of Science:
- Epigenetics
- Cancer Biology
- Chemical Genetics
Background:
- Core regulatory (CR) transcription factors (TFs) drive cell identity and are regulated by super enhancers (SEs).
- Targeting CR circuitry with drugs is a key strategy for cancer treatment.
- Alveolar rhabdomyosarcoma, driven by PAX3-FOXO1, serves as a model for cancer cell dependence on CR transcription.
Purpose of the Study:
- To screen for epigenetic chemical probes that can differentiate between SE-driven and constitutive transcription.
- To identify specific epigenetic mechanisms regulating CR transcription in cancer.
Main Methods:
- Utilized chemical genetics for systematic screening of chemical matter.
- Employed a screen for epigenetic chemical probes targeting transcription.
- Investigated histone deacetylase (HDAC) isoform contributions using selective inhibitors, including a novel HDAC3 inhibitor (LW3).
Main Results:
- Chemical probes targeting the acetylation axis, but not the methylation axis, selectively disrupted CR transcription.
- Histone deacetylases (HDACs) were found to be essential for CR TF transcription.
- Co-inhibition of HDAC1, HDAC2, and HDAC3 halted CR transcription, leading to hyper-accessible CR TF sites and disrupted chromatin looping.
Conclusions:
- Epigenetic regulation via acetylation is crucial for maintaining cancer-driving CR transcription.
- HDAC1, HDAC2, and HDAC3 are co-essential for CR transcription and represent potential therapeutic targets.
- Disrupting this HDAC network offers a novel approach to halt cancer transcription and chromatin organization.
Related Concept Videos
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Cis-regulatory Sequences
Transcription Elongation Factors
The transcription elongation is regulated via pausing of RNA polymerase on several occasions during transcription. In bacteria, these halts are necessary because the transcription of DNA into mRNA is coupled to the translation of that mRNA...
Cooperative Binding of Transcription Regulators
Histone Variants at the Centromere

